The Promise of Plasma Therapy

As survivors of the Coronavirus emerge from hospitals across the country, they bring with them a cherished hope we’ve all longed for. And not just because they’ve survived (though that is joyous), but because as a result of their illness we now have access to Coronavirus resistant antibodies.

Blood banks across the country are working with these individuals to collect and use their plasma in an effort to pass immunity to those who are severely ill. Known as Convalescent Plasma Therapy, this treatment has the potential to reduce the duration and severity of COVID-19.

While Convalescent Plasma Therapy has existed for some time, its application against COVID-19 is new, and blood banks are working quickly to adapt. To help with their efforts the team at Shamrock has developed a series of pre-printed, ISBT compliant Convalescent Plasma labels that can be used to correctly identify these products for transportation and administration.

Knowing the urgent need that these and other COVID-19 related products represent, our team is working around the clock to expedite their production. Most orders are shipping within a matter of days.